series-c-plus
Stage
2016
Founded
3
Investors
About
Develops transcatheter heart valve replacement systems for minimally invasive treatment of valvular heart disease; products target transcatheter aortic and mitral valve replacement (TAVR and TMVR).
Explore JenaValve Technology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.